IP
CELG

Intellectus Partners’s Celgene Corp CELG Stock Holding History

Intellectus Partners’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-22,252
Closed -$2.21M – 213
2019
Q3 		$2.21M Sell
22,252
-166
-0.7% -$15.8K 0.97% 21
2019
Q2 		$2.07M Sell
22,418
-1,044
-4% -$99.1K 0.9% 24
2019
Q1 		$2.21M Buy
23,462
+63
+0.3% +$5.51K 0.95% 20
2018
Q4 		$1.5M Sell
23,399
-4,322
-16% -$319K 1.03% 22
2018
Q3 		$2.48M Sell
27,721
-2,965
-10% -$262K 0.87% 22
2018
Q2 		$2.44M Buy
30,686
+2,722
+10% +$226K 0.89% 22
2018
Q1 		$2.5M Sell
27,964
-3,676
-12% -$353K 0.86% 20
2017
Q4 		$3.3M Buy
31,640
+10,757
+52% +$1.21M 1.23% 13
2017
Q3 		$3.04M Sell
20,883
-294
-1% -$40K 1.26% 10
2017
Q2 		$2.75M Buy
21,177
+3,247
+18% +$398K 1.24% 12
2017
Q1 		$2.23M Sell
17,930
-379
-2% -$45.4K 1.13% 12
2016
Q4 		$2.12M Buy
+18,309
New +$2.04M 1.1% 12

Other funds holding CELG

HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Intellectus Partners's CELG Position: Q4 2019 in Review

Intellectus Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 22,252 shares — an estimated $2.21M sold.

Intellectus Partners first reported a position in CELG in Q4 2016 and held it in 12 quarters. The position peaked at $3.3M in Q4 2017. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Intellectus Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Intellectus Partners sold 22,252 Celgene Corp shares in Q4 2019, an estimated $2.21M.
  • Intellectus Partners first reported a position in Celgene Corp in Q4 2016 and held it in 12 quarters.
  • Intellectus Partners's Celgene Corp position peaked at $3.3M in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Intellectus Partners's 13F filing for Q4 2019, filed 24 Jan 2020.